For an amture and you are right this is just a hobby for me, you are certainly trying hard to explain NOX's case against my "ignorance".... and I appreciate that. The LIPROSE delivery, tell me if I have this wrong is the following concept but now the active ingredients are dissolved into the base.
" Preparation of cocoa butter formulation for rectal dosing: Briefly, 100 mg of the cocoa butter was weighed into a homogenizer glass tube and melted at 32 degrees Celsius. 3 mg of idronoxil was then added and the formulation mixed manually with the homogenizer."
https://patentscope.wipo.int/search...queryString=FP:(noxopharm)&tab=PCTDescription
And the new unpublished IP is the form of the isoflavonoids after they have been delivered via a lipid base ? Have I got this right.
Add to My Watchlist
What is My Watchlist?
